Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals Revenue 2010-2025 | REGN

Regeneron Pharmaceuticals annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Regeneron Pharmaceuticals revenue for the quarter ending March 31, 2025 was $3.029B, a 3.7% decline year-over-year.
  • Regeneron Pharmaceuticals revenue for the twelve months ending March 31, 2025 was $14.086B, a 7.52% increase year-over-year.
  • Regeneron Pharmaceuticals annual revenue for 2024 was $14.202B, a 8.27% increase from 2023.
  • Regeneron Pharmaceuticals annual revenue for 2023 was $13.117B, a 7.76% increase from 2022.
  • Regeneron Pharmaceuticals annual revenue for 2022 was $12.173B, a 24.26% decline from 2021.
  
Regeneron Pharmaceuticals Annual Revenue
(Millions of US $)
2024 $14,202
2023 $13,117
2022 $12,173
2021 $16,072
2020 $8,497
2019 $6,558
2018 $5,146
2017 $5,872
2016 $4,860
2015 $4,104
2014 $2,820
2013 $2,105
2012 $1,378
2011 $446
2010 $459
2009 $379
Regeneron Pharmaceuticals Quarterly Revenue
(Millions of US $)
2025-03-31 $3,029
2024-12-31 $3,789
2024-09-30 $3,721
2024-06-30 $3,547
2024-03-31 $3,145
2023-12-31 $3,434
2023-09-30 $3,363
2023-06-30 $3,158
2023-03-31 $3,162
2022-12-31 $3,414
2022-09-30 $2,936
2022-06-30 $2,857
2022-03-31 $2,965
2021-12-31 $4,952
2021-09-30 $3,453
2021-06-30 $5,139
2021-03-31 $2,529
2020-12-31 $2,423
2020-09-30 $2,294
2020-06-30 $1,952
2020-03-31 $1,828
2019-12-31 $1,864
2019-09-30 $1,744
2019-06-30 $1,578
2019-03-31 $1,373
2018-12-31 $363
2018-09-30 $1,664
2018-06-30 $1,608
2018-03-31 $1,512
2017-12-31 $1,582
2017-09-30 $1,501
2017-06-30 $1,470
2017-03-31 $1,319
2016-12-31 $1,227
2016-09-30 $1,220
2016-06-30 $1,213
2016-03-31 $1,201
2015-12-31 $1,098
2015-09-30 $1,137
2015-06-30 $999
2015-03-31 $870
2014-12-31 $802
2014-09-30 $726
2014-06-30 $666
2014-03-31 $626
2013-12-31 $610
2013-09-30 $597
2013-06-30 $458
2013-03-31 $440
2012-12-31 $415
2012-09-30 $428
2012-06-30 $304
2012-03-31 $232
2011-12-31 $123
2011-09-30 $103
2011-06-30 $108
2011-03-31 $112
2010-12-31 $134
2010-09-30 $106
2010-06-30 $116
2010-03-31 $104
2009-12-31 $97
2009-09-30 $117
2009-06-30 $90
2009-03-31 $75
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $66.376B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $216.839B 16.18
Amgen (AMGN) United States $147.875B 13.25
Gilead Sciences (GILD) United States $135.725B 14.10
Vertex Pharmaceuticals (VRTX) United States $114.835B 0.00
Bristol Myers Squibb (BMY) United States $97.419B 6.52
GSK (GSK) United Kingdom $79.228B 9.41
CSL (CSLLY) Australia $75.857B 0.00
Alnylam Pharmaceuticals (ALNY) United States $38.032B 0.00
Argenex SE (ARGX) Netherlands $35.311B 96.39
BioNTech SE (BNTX) Germany $24.453B 0.00
BeiGene (ONC) Cayman Islands $23.460B 0.00
Biogen (BIIB) United States $19.129B 8.25
Royalty Pharma (RPRX) United States $19.075B 7.86
Illumina (ILMN) United States $13.330B 25.29
Genmab (GNMSF) Denmark $13.172B 13.47
Genmab (GMAB) Denmark $13.036B 14.63
Incyte (INCY) United States $12.640B 96.03
Insmed (INSM) United States $12.478B 0.00
Exelixis (EXEL) United States $12.097B 20.54
BioMarin Pharmaceutical (BMRN) United States $11.493B 18.67
Exact Sciences (EXAS) United States $10.905B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.858B 27.73
Moderna (MRNA) United States $10.825B 0.00
Ascendis Pharma (ASND) Denmark $9.851B 0.00
QIAGEN (QGEN) Netherlands $9.492B 18.47
Roivant Sciences (ROIV) United Kingdom $7.878B 0.00
Bio-Techne Corp (TECH) United States $7.765B 28.97
Revolution Medicines (RVMD) United States $7.538B 0.00
Repligen (RGEN) United States $7.168B 80.25
Jazz Pharmaceuticals (JAZZ) Ireland $6.842B 6.60
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Blueprint Medicines (BPMC) United States $6.652B 0.00
Halozyme Therapeutics (HALO) United States $6.586B 12.61
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.362B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $5.850B 0.00
TG Therapeutics (TGTX) United States $5.631B 147.79
Telix Pharmaceuticals (TLX) Australia $5.543B 0.00
Legend Biotech (LEGN) United States $5.526B 0.00
Nuvalent (NUVL) United States $5.433B 0.00
Axsome Therapeutics (AXSM) United States $5.335B 0.00
Alkermes (ALKS) Ireland $5.222B 14.01
Guardant Health (GH) United States $4.952B 0.00
ADMA Biologics Inc (ADMA) United States $4.880B 36.50
Vaxcyte (PCVX) United States $4.718B 0.00
Zealand Pharma (ZLDPF) Denmark $4.504B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.064B 0.00
Sarepta Therapeutics (SRPT) United States $3.930B 0.00
Cytokinetics (CYTK) United States $3.901B 0.00
Avidity Biosciences (RNA) United States $3.813B 0.00
Krystal Biotech (KRYS) United States $3.801B 29.30
Akero Therapeutics (AKRO) United States $3.792B 0.00
PTC Therapeutics (PTCT) United States $3.741B 6.51
ACADIA Pharmaceuticals (ACAD) United States $3.630B 31.90
Zai Lab (ZLAB) China $3.600B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.531B 0.00
SpringWorks Therapeutics (SWTX) United States $3.489B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.390B 0.00
Arcellx (ACLX) United States $3.336B 0.00
Viking Therapeutics (VKTX) United States $3.220B 0.00
Metsera (MTSR) United States $3.073B 0.00
Merus (MRUS) Netherlands $3.046B 0.00
Scholar Rock Holding (SRRK) United States $2.995B 0.00
Alvotech (ALVO) Luxembourg $2.948B 16.86
Protagonist Therapeutics (PTGX) United States $2.889B 62.15
MoonLake Immunotherapeutics (MLTX) Switzerland $2.578B 0.00
ImmunityBio (IBRX) United States $2.560B 0.00
Immunovant (IMVT) United States $2.548B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.412B 0.00
Apellis Pharmaceuticals (APLS) United States $2.326B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.313B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.250B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.246B 0.00
Vericel (VCEL) United States $2.191B 1450.67
Denali Therapeutics (DNLI) United States $2.076B 0.00
Belite Bio (BLTE) United States $2.063B 0.00
Kymera Therapeutics (KYMR) United States $2.047B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.045B 13.60
Bavarian Nordic (BVNRY) Denmark $2.030B 10.73
Amicus Therapeutics (FOLD) United States $2.029B 219.67
NovoCure (NVCR) Jersey $2.029B 0.00
CG Oncology (CGON) United States $2.025B 0.00
Ligand Pharmaceuticals (LGND) United States $2.024B 0.00
Ascentage Pharma Group - (AAPG) China $2.003B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.948B 0.00
Certara (CERT) United States $1.897B 35.42
Tarsus Pharmaceuticals (TARS) United States $1.886B 0.00
Apogee Therapeutics (APGE) United States $1.858B 0.00
Twist Bioscience (TWST) United States $1.852B 0.00
Beam Therapeutics (BEAM) United States $1.785B 0.00
Agios Pharmaceuticals (AGIO) United States $1.747B 0.00
Disc Medicine (IRON) United States $1.734B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.730B 0.00
IDEAYA Biosciences (IDYA) United States $1.719B 0.00
Biohaven (BHVN) United States $1.659B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.622B 0.00
Edgewise Therapeutics (EWTX) United States $1.564B 0.00
Travere Therapeutics (TVTX) United States $1.559B 0.00
Janux Therapeutics (JANX) United States $1.503B 0.00
Mesoblast (MESO) Australia $1.475B 0.00
Liquidia Technologies (LQDA) United States $1.455B 0.00
Adaptive Biotechnologies (ADPT) United States $1.422B 0.00
Structure Therapeutics (GPCR) United States $1.415B 0.00
GRAIL (GRAL) United States $1.414B 0.00
Celldex Therapeutics (CLDX) United States $1.360B 0.00
Vera Therapeutics (VERA) United States $1.355B 0.00
MannKind (MNKD) United States $1.324B 27.22
89BIO (ETNB) United States $1.318B 0.00
ANI Pharmaceuticals (ANIP) United States $1.314B 13.54
Dynavax Technologies (DVAX) United States $1.251B 74.43
Novavax (NVAX) United States $1.244B 2.90
Pacira BioSciences (PCRX) United States $1.238B 11.78
BGM Group (BGM) China $1.201B 0.00
Anbio Biotechnology (NNNN) Germany $1.151B 0.00
Viridian Therapeutics (VRDN) United States $1.128B 0.00
Gyre Therapeutics (GYRE) United States $1.069B 285.00
MiMedx (MDXG) United States $1.059B 25.61
Mineralys Therapeutics (MLYS) United States $1.049B 0.00
NeoGenomics (NEO) United States $1.028B 0.00
WAVE Life Sciences (WVE) Singapore $1.008B 0.00
Intellia Therapeutics (NTLA) United States $1.002B 0.00
CureVac (CVAC) Germany $0.960B 5.22
Arcus Biosciences (RCUS) United States $0.939B 0.00
Spyre Therapeutics (SYRE) United States $0.928B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.910B 0.00
Pharvaris (PHVS) Netherlands $0.902B 0.00
Geron (GERN) United States $0.885B 0.00
CorMedix Inc (CRMD) United States $0.870B 58.27
Zymeworks (ZYME) United States $0.865B 0.00
Niagen Bioscience (NAGE) United States $0.848B 119.56
UniQure (QURE) Netherlands $0.839B 0.00
Bicara Therapeutics (BCAX) United States $0.820B 0.00
Praxis Precision Medicines (PRAX) United States $0.809B 0.00
LENZ Therapeutics (LENZ) United States $0.809B 0.00
Nurix Therapeutics (NRIX) United States $0.773B 0.00
Oculis Holding AG (OCS) Switzerland $0.768B 0.00
Immunome (IMNM) United States $0.745B 0.00
Nuvation Bio (NUVB) United States $0.738B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.731B 0.00
ArriVent BioPharma (AVBP) United States $0.714B 0.00
Replimune (REPL) United States $0.708B 0.00
Pharming Group (PHAR) Netherlands $0.682B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.667B 0.00
Immatics (IMTX) Germany $0.656B 0.00
Vir Biotechnology (VIR) United States $0.654B 0.00
GH Research (GHRS) Ireland $0.648B 0.00
Trevi Therapeutics (TRVI) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Anavex Life Sciences (AVXL) United States $0.643B 0.00
Iovance Biotherapeutics (IOVA) United States $0.638B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
AbCellera Biologics (ABCL) Canada $0.624B 0.00
AnaptysBio (ANAB) United States $0.620B 0.00
Sionna Therapeutics (SION) United States $0.618B 0.00
Arbutus Biopharma (ABUS) United States $0.615B 0.00
Dianthus Therapeutics (DNTH) United States $0.615B 0.00
Cogent Biosciences (COGT) United States $0.605B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.589B 0.00
Keros Therapeutics (KROS) United States $0.574B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.573B 0.00
Kura Oncology (KURA) United States $0.552B 0.00
Stoke Therapeutics (STOK) United States $0.549B 12.72
Tyra Biosciences (TYRA) United States $0.530B 0.00
Eton Pharmaceuticals (ETON) United States $0.526B 0.00
Opthea (OPT) Australia $0.525B 0.00
REGENXBIO (RGNX) United States $0.502B 0.00
Upstream Bio (UPB) United States $0.491B 0.00
Arvinas (ARVN) United States $0.485B 0.00
Zenas BioPharma (ZBIO) United States $0.480B 0.00
Castle Biosciences (CSTL) United States $0.476B 32.35
Sana Biotechnology (SANA) United States $0.471B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.468B 0.00
Cullinan Therapeutics (CGEM) United States $0.466B 0.00
Tectonic Therapeutic (TECX) United States $0.459B 0.00
Sage Therapeutics (SAGE) United States $0.446B 0.00
Maze Therapeutics (MAZE) United States $0.443B 0.00
MeiraGTx Holdings (MGTX) United States $0.442B 0.00
Verastem (VSTM) United States $0.441B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.427B 0.00
Fortrea Holdings (FTRE) United States $0.424B 11.73
Septerna (SEPN) United States $0.420B 0.00
PureTech Health (PRTC) United States $0.419B 0.00
Northwest Biotherapeutics (NWBO) United States $0.416B 0.00
Precigen (PGEN) United States $0.416B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
MBX Biosciences (MBX) United States $0.413B 0.00
Myriad Genetics (MYGN) United States $0.410B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.407B 0.00
Celcuity (CELC) United States $0.403B 0.00
Oric Pharmaceuticals (ORIC) United States $0.403B 0.00
Kamada (KMDA) Israel $0.395B 23.69
Prothena (PRTA) Ireland $0.392B 0.00
Humacyte (HUMA) United States $0.386B 0.00
Emergent Biosolutions (EBS) United States $0.377B 0.00
Rapport Therapeutics (RAPP) United States $0.373B 0.00
Abivax SA (ABVX) France $0.368B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.366B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.366B 0.00
Erasca (ERAS) United States $0.363B 0.00
Alpha Teknova (TKNO) United States $0.359B 0.00
Benitec Biopharma (BNTC) United States $0.357B 0.00
Absci (ABSI) United States $0.356B 0.00
Fulcrum Therapeutics (FULC) United States $0.351B 0.00
Checkpoint Therapeutics (CKPT) United States $0.348B 0.00
Urogen Pharma (URGN) United States $0.348B 0.00
Olema Pharmaceuticals (OLMA) United States $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.344B 0.00
Cidara Therapeutics (CDTX) United States $0.338B 0.00
Cytek Biosciences (CTKB) United States $0.337B 0.00
Abeona Therapeutics (ABEO) United States $0.328B 0.00
ITeos Therapeutics (ITOS) United States $0.320B 0.00
XOMA Royalty (XOMA) United States $0.318B 0.00
Entrada Therapeutics (TRDA) United States $0.313B 10.17
ATyr Pharma (ATYR) United States $0.311B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.306B 0.00
Aura Biosciences (AURA) United States $0.298B 0.00
Candel Therapeutics (CADL) United States $0.296B 0.00
Prima BioMed (IMMP) Australia $0.294B 0.00
Compass Therapeutics (CMPX) United States $0.290B 0.00
Terns Pharmaceuticals (TERN) United States $0.275B 0.00
Gossamer Bio (GOSS) United States $0.268B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Cartesian Therapeutics (RNAC) United States $0.266B 0.00
Neurogene (NGNE) United States $0.265B 0.00
DBV Technologies S.A (DBVT) France $0.263B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.262B 0.00
Palvella Therapeutics (PVLA) United States $0.257B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.256B 52.00
Inozyme Pharma (INZY) United States $0.255B 0.00
Allogene Therapeutics (ALLO) United States $0.254B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.251B 0.00
Atea Pharmaceuticals (AVIR) United States $0.248B 0.00
Lifecore Biomedical (LFCR) United States $0.245B 0.00
Astria Therapeutics (ATXS) United States $0.242B 0.00
Rezolute (RZLT) United States $0.239B 0.00
Aardvark Therapeutics (AARD) United States $0.239B 0.00
Ocugen (OCGN) United States $0.237B 0.00
Third Harmonic Bio (THRD) United States $0.235B 0.00
MaxCyte (MXCT) United States $0.232B 0.00
Foghorn Therapeutics (FHTX) United States $0.231B 0.00
Alumis (ALMS) United States $0.230B 0.00
Annexon (ANNX) United States $0.230B 0.00
Amarin (AMRN) Ireland $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Solid Biosciences (SLDB) United States $0.229B 0.00
Bright Minds Biosciences (DRUG) United States $0.229B 0.00
Adherex Technologies (FENC) United States $0.226B 0.00
Monopar Therapeutics (MNPR) United States $0.226B 0.00
Tango Therapeutics (TNGX) United States $0.224B 0.00
Nuvectis Pharma (NVCT) United States $0.223B 0.00
GENFIT S.A (GNFT) France $0.216B 0.00
Kodiak Sciences (KOD) United States $0.214B 0.00
EnGene Holdings (ENGN) Canada $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Semper Paratus Acquisition (TVGN) United States $0.213B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.213B 0.00
Design Therapeutics (DSGN) United States $0.208B 0.00
Actuate Therapeutics (ACTU) United States $0.208B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.206B 0.00
Cardiff Oncology (CRDF) United States $0.204B 0.00
Codexis (CDXS) United States $0.203B 0.00
BioStem Technologies (BSEM) $0.201B 8.18
Innate Pharma S.A (IPHA) France $0.195B 0.00
Galena Biopharma (SLS) United States $0.194B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.192B 0.00
Inhibrx Biosciences (INBX) United States $0.189B 0.11
CARGO Therapeutics (CRGX) United States $0.189B 0.00
Voyager Therapeutics (VYGR) United States $0.188B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.185B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.183B 0.00
Puma Biotechnology (PBYI) United States $0.180B 4.71
DiaMedica Therapeutics (DMAC) United States $0.177B 0.00
INmune Bio (INMB) United States $0.177B 0.00
AC Immune (ACIU) Switzerland $0.176B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.175B 0.00
ScPharmaceuticals (SCPH) United States $0.174B 0.00
Inventiva S.A (IVA) France $0.173B 0.00
Anika Therapeutics (ANIK) United States $0.172B 0.00
Alpha Cognition (ACOG) Canada $0.169B 0.00
CytomX Therapeutics (CTMX) United States $0.166B 4.29
TuHURA Biosciences (HURA) United States $0.162B 0.00
Molecular Partners AG (MOLN) Switzerland $0.159B 0.00
Prime Medicine (PRME) United States $0.154B 0.00
BioAge Labs (BIOA) United States $0.147B 0.00
Fate Therapeutics (FATE) United States $0.143B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.140B 0.00
Editas Medicine (EDIT) United States $0.137B 0.00
Alector (ALEC) United States $0.137B 0.00
Greenwich LifeSciences (GLSI) United States $0.137B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Rapt Therapeutics (RAPT) United States $0.127B 0.00
EXoZymes (EXOZ) United States $0.126B 0.00
Compugen (CGEN) Israel $0.126B 0.00
Seer (SEER) United States $0.125B 0.00
Black Diamond Therapeutics (BDTX) United States $0.123B 36.17
Theratechnologies (THTX) Canada $0.120B 0.00
InflaRx (IFRX) Germany $0.119B 0.00
Neumora Therapeutics (NMRA) United States $0.118B 0.00
Sangamo Therapeutics (SGMO) United States $0.116B 0.00
Vigil Neuroscience (VIGL) United States $0.116B 0.00
Ventyx Biosciences (VTYX) United States $0.113B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.113B 0.00
Instil Bio (TIL) United States $0.108B 0.00
Agenus (AGEN) United States $0.105B 0.00
Sagimet Biosciences (SGMT) United States $0.105B 0.00
C4 Therapeutics (CCCC) United States $0.105B 0.00
Genelux (GNLX) United States $0.104B 0.00
Nautilus Biotechnology (NAUT) United States $0.104B 0.00
Kyverna Therapeutics (KYTX) United States $0.103B 0.00
Medicus Pharma (MDCX) United States $0.103B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Caribou Biosciences (CRBU) United States $0.102B 0.00
HilleVax (HLVX) United States $0.101B 0.00
Contineum Therapeutics (CTNM) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Invivyd (IVVD) United States $0.097B 0.00
Cabaletta Bio (CABA) United States $0.095B 0.00
Coherus BioSciences (CHRS) United States $0.095B 0.00
Entera Bio (ENTX) Israel $0.094B 0.00
Immunic (IMUX) United States $0.093B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.092B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.092B 0.00
XBiotech (XBIT) United States $0.091B 0.00
23andMe Holding (MEHCQ) United States $0.090B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.089B 0.00
Elicio Therapeutics (ELTX) United States $0.088B 0.00
Tvardi Therapeutics (TVRD) United States $0.086B 0.00
Cellectis S.A (CLLS) France $0.086B 0.00
Pliant Therapeutics (PLRX) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Climb Bio (CLYM) United States $0.084B 0.00
Senti Biosciences (SNTI) United States $0.083B 0.00
Genenta Science S.p.A (GNTA) Italy $0.081B 0.00
Alto Neuroscience (ANRO) United States $0.079B 0.00
Inovio Pharmaceuticals (INO) United States $0.078B 0.00
Tenaya Therapeutics (TNYA) United States $0.077B 0.00
CervoMed (CRVO) United States $0.076B 0.00
Sutro Biopharma (STRO) United States $0.076B 0.00
VistaGen Therapeutics (VTGN) United States $0.076B 0.00
Jasper Therapeutics (JSPR) United States $0.076B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.075B 0.00
I-Mab (IMAB) United States $0.075B 0.00
PDS Biotechnology (PDSB) United States $0.075B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
Elutia (ELUT) United States $0.074B 0.00
IGM Biosciences (IGMS) United States $0.074B 0.00
Adagene (ADAG) China $0.073B 0.00
Zura Bio (ZURA) United States $0.073B 0.00
Seres Therapeutics (MCRB) United States $0.072B 0.00
Adlai Nortye (ANL) Cayman Islands $0.070B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
TScan Therapeutics (TCRX) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
IO Biotech (IOBT) Denmark $0.068B 0.00
MediciNova (MNOV) United States $0.067B 0.00
VTv Therapeutics (VTVT) United States $0.066B 0.00
Exicure (XCUR) United States $0.064B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.064B 0.00
Citius Oncology (CTOR) United States $0.064B 0.00
OKYO Pharma (OKYO) $0.063B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
Applied Therapeutics (APLT) United States $0.062B 0.00
Skye Bioscience (SKYE) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Biomea Fusion (BMEA) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.059B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Immuneering (IMRX) United States $0.057B 0.00
Celularity (CELU) United States $0.055B 0.00
Ikena Oncology (IKNA) United States $0.055B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
Akoya Biosciences (AKYA) United States $0.053B 0.00
Artiva Biotherapeutics (ARTV) United States $0.053B 0.00
TELA Bio (TELA) United States $0.053B 0.00
Adverum Biotechnologies (ADVM) United States $0.052B 0.00
Fortress Biotech (FBIO) United States $0.052B 0.00
PepGen (PEPG) United States $0.052B 0.00
Werewolf Therapeutics (HOWL) United States $0.051B 0.00
Cue Biopharma (CUE) United States $0.050B 0.00
Forte Biosciences (FBRX) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Shattuck Labs (STTK) United States $0.049B 0.00
Whitehawk Therapeutics (WHWK) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Mersana Therapeutics (MRSN) United States $0.049B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.048B 0.00
Connect Biopharma Holdings (CNTB) United States $0.047B 0.00
Xilio Therapeutics (XLO) United States $0.047B 0.00
Quince Therapeutics (QNCX) United States $0.046B 0.00
Opus Genetics (IRD) United States $0.045B 0.00
CAMP4 Therapeutics (CAMP) United States $0.045B 0.00
RenovoRx (RNXT) United States $0.045B 0.00
Rani Therapeutics Holdings (RANI) United States $0.043B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.042B 0.00
Atara Biotherapeutics (ATRA) United States $0.042B 0.00
Annovis Bio (ANVS) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.042B 0.00
Kronos Bio (KRON) United States $0.041B 0.00
Pluri (PLUR) Israel $0.038B 0.00
Spero Therapeutics (SPRO) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Alterity Therapeutics - (ATHE) Australia $0.037B 0.00
Boundless Bio (BOLD) United States $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.037B 0.00
Aligos Therapeutics (ALGS) United States $0.037B 0.00
AN2 Therapeutics (ANTX) United States $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.035B 0.00
FibroBiologics (FBLG) United States $0.035B 0.00
Scilex Holding (SCLX) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.034B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
Dyadic (DYAI) United States $0.032B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
Cadrenal Therapeutics (CVKD) United States $0.031B 0.00
Quantum Biopharma (QNTM) Canada $0.031B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.027B 0.00
Generation Bio (GBIO) United States $0.027B 0.00
Advanced Biomed (ADVB) United States $0.026B 0.00
CalciMedica (CALC) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
KALA BIO (KALA) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Clene (CLNN) United States $0.023B 0.00
ABVC BioPharma (ABVC) United States $0.023B 0.00
ALX Oncology Holdings (ALXO) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.023B 0.00
Vor Biopharma (VOR) $0.022B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.022B 0.00
Curis (CRIS) United States $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
HOOKIPA Pharma (HOOK) United States $0.021B 0.00
Cognition Therapeutics (CGTX) United States $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Elevation Oncology (ELEV) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Kalaris Therapeutics (KLRS) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
Gelteq (GELS) Australia $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
X4 Pharmaceuticals (XFOR) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Moleculin Biotech (MBRX) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Synlogic (SYBX) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
HCW Biologics (HCWB) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.013B 0.00
IN8bio (INAB) United States $0.012B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
LakeShore Biopharma (LSB) China $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
Athira Pharma (ATHA) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.009B 0.00
IMMURON (IMRN) Australia $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
BioXcel Therapeutics (BTAI) United States $0.009B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Imunon (IMNN) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
180 Life Sciences (ATNF) United States $0.007B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
MetaVia (MTVA) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Onconetix (ONCO) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
BioAffinity Technologies (BIAF) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Eyenovia (EYEN) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Evaxion Biotech (EVAX) Denmark $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Polyrizon (PLRZ) Israel $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00